Literature DB >> 29442265

Integrated mRNA and miRNA profiling revealed deregulation of cellular stress response in bone marrow mesenchymal stem cells derived from patients with immune thrombocytopenia.

Jia-Min Zhang1,2,3, Xiao-Lu Zhu1,2,3, Jing Xue1,2, Xiao Liu1,2, X Long Zheng4, Ying-Jun Chang1,2, Kai-Yan Liu1,2,3, Xiao-Jun Huang1,2,3, Xiao-Hui Zhang5,6,7.   

Abstract

Our understanding of the pathogenesis of immune thrombocytopenia (ITP) remains limited due to the complexity and heterogeneity of the disease. Recently, we observed that bone marrow mesenchymal stem cells (MSCs) derived from ITP patients exhibited growth defects and functional abnormalities that might be involved in the breakdown of self-tolerance. However, the underlying mechanism remains unclear. In this study, we profiled the expression of both mRNAs and miRNAs by utilizing the microarray technique and deciphered the mechanism underlying the impairment of MSCs derived from ITP patients (MSC-ITP). In total, we identified 740 genes and 32 miRNAs that were differentially expressed between ITP patients and controls. A compromised unfolded protein response (UPR) and decreased DNA transcription were shown to be significantly related to MSC-ITP. The interaction of miRNA with mRNA suggested that the cellular stress response, the UPR, and DNA transcription may be involved in the defects observed in MSC-ITP. Key differentially expressed genes were further validated by RT-PCR. Our results highlight that defects in the cellular stress response, as shown by a compromised UPR and differential DNA transcription, play key roles in causing the abnormalities observed in MSC-ITP. These data might contribute to a better understanding of the abnormal bone marrow niche and provide new insights into the pathogenesis of ITP.

Entities:  

Keywords:  Cellular stress response; DNA transcription; Immune thrombocytopenia; Mesenchymal stem cells; Microarray; Unfolded protein response

Mesh:

Substances:

Year:  2018        PMID: 29442265     DOI: 10.1007/s10142-018-0591-2

Source DB:  PubMed          Journal:  Funct Integr Genomics        ISSN: 1438-793X            Impact factor:   3.410


  35 in total

Review 1.  Mechanisms of gene silencing by double-stranded RNA.

Authors:  Gunter Meister; Thomas Tuschl
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

2.  Intrinsically impaired platelet production in some patients with persistent or chronic immune thrombocytopenia.

Authors:  Étienne Rivière; Jean-François Viallard; Alexandre Guy; Badr Kilani; Juliana Vieira-Dias; Anne C Pons; Thierry Couffinhal; Jean-Luc Pellegrin; Chloé James
Journal:  Br J Haematol       Date:  2015-04-14       Impact factor: 6.998

Review 3.  The transcription stress response.

Authors:  Mats Ljungman
Journal:  Cell Cycle       Date:  2007-07-16       Impact factor: 4.534

Review 4.  Interactions between mesenchymal stem cells and the immune system.

Authors:  Na Li; Jinlian Hua
Journal:  Cell Mol Life Sci       Date:  2017-02-18       Impact factor: 9.261

5.  Platelet-Derived Growth Factor-BB Protects Mesenchymal Stem Cells (MSCs) Derived From Immune Thrombocytopenia Patients Against Apoptosis and Senescence and Maintains MSC-Mediated Immunosuppression.

Authors:  Jia-Min Zhang; Fei-Er Feng; Qian-Ming Wang; Xiao-Lu Zhu; Hai-Xia Fu; Lan-Ping Xu; Kai-Yan Liu; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Stem Cells Transl Med       Date:  2016-07-28       Impact factor: 6.940

Review 6.  Eukaryotic transcription factors: paradigms of protein intrinsic disorder.

Authors:  Lasse Staby; Charlotte O'Shea; Martin Willemoës; Frederik Theisen; Birthe B Kragelund; Karen Skriver
Journal:  Biochem J       Date:  2017-07-12       Impact factor: 3.857

7.  Favorable response of chronic refractory immune thrombocytopenic purpura to mesenchymal stem cells.

Authors:  Baijun Fang; Ling Mai; Ning Li; Yongping Song
Journal:  Stem Cells Dev       Date:  2011-08-12       Impact factor: 3.272

8.  MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2.

Authors:  Grazia Maria Spaggiari; Heba Abdelrazik; Flavio Becchetti; Lorenzo Moretta
Journal:  Blood       Date:  2009-04-27       Impact factor: 22.113

9.  Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

Authors:  Jose Antonio Pérez-Simón; Soraya Tabera; María Eugenia Sarasquete; María Díez-Campelo; Javier Canchado; Luis Ignacio Sánchez-Abarca; Belén Blanco; Ignacio Alberca; Carmen Herrero-Sánchez; Consuelo Cañizo; Jesús F San Miguel
Journal:  Cytotherapy       Date:  2009       Impact factor: 5.414

10.  NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.

Authors:  M R Emma; J L Iovanna; D Bachvarov; R Puleio; G R Loria; G Augello; S Candido; M Libra; A Gulino; V Cancila; J A McCubrey; G Montalto; M Cervello
Journal:  Cell Death Dis       Date:  2016-06-23       Impact factor: 8.469

View more
  4 in total

Review 1.  The Extensive Regulation of MicroRNA in Immune Thrombocytopenia.

Authors:  Yuerong Zhao; Siyuan Cui; Yan Wang; Ruirong Xu
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

2.  miRNA-98-5p Targeting IGF2BP1 Induces Mesenchymal Stem Cell Apoptosis by Modulating PI3K/Akt and p53 in Immune Thrombocytopenia.

Authors:  Yanan Wang; Jiamin Zhang; Yan Su; Chencong Wang; Gaochao Zhang; Xiao Liu; Qi Chen; Meng Lv; Yingjun Chang; Jun Peng; Ming Hou; Xiaojun Huang; Xiaohui Zhang
Journal:  Mol Ther Nucleic Acids       Date:  2020-05-01       Impact factor: 8.886

Review 3.  The Endocannabinoid System in Pediatric Inflammatory and Immune Diseases.

Authors:  Maura Argenziano; Chiara Tortora; Giulia Bellini; Alessandra Di Paola; Francesca Punzo; Francesca Rossi
Journal:  Int J Mol Sci       Date:  2019-11-23       Impact factor: 5.923

4.  Eltrombopag in paediatric immune thrombocytopenia: Iron metabolism modulation in mesenchymal stromal cells.

Authors:  Alessandra Di Paola; Giuseppe Palumbo; Chiara Tortora; Maura Argenziano; Marialuigia Catanoso; Caterina Di Leva; Giulia Ceglie; Silverio Perrotta; Franco Locatelli; Francesca Rossi
Journal:  Br J Haematol       Date:  2021-12-28       Impact factor: 8.615

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.